Abstract
ObjectivesTo investigate the impact of disease activity, functional capacity and treatment with biologic and non-biologic disease modifying anti-rheumatic drugs (bDMARDs, nbDMARDs) on mortality risk in patients with rheumatoid arthrits (RA)...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have